Literature DB >> 32015526

Genomic landscape of lung adenocarcinoma in East Asians.

Jianbin Chen1, Hechuan Yang1,2, Audrey Su Min Teo1, Lidyana Bte Amer1, Faranak Ghazi Sherbaf1, Chu Quan Tan1, Jacob Josiah Santiago Alvarez1, Bingxin Lu1, Jia Qi Lim1, Angela Takano3, Rahul Nahar1, Yin Yeng Lee1, Cheryl Zi Jin Phua1, Khi Pin Chua1, Lisda Suteja4, Pauline Jieqi Chen1, Mei Mei Chang1, Tina Puay Theng Koh5, Boon-Hean Ong6, Devanand Anantham7, Anne Ann Ling Hsu7, Apoorva Gogna8, Chow Wei Too8, Zaw Win Aung9, Yi Fei Lee1,10, Lanying Wang9, Tony Kiat Hon Lim3, Andreas Wilm1, Poh Sum Choi1, Poh Yong Ng1, Chee Keong Toh4, Wan-Teck Lim4,11, Siming Ma1, Bing Lim1, Jin Liu12, Wai Leong Tam1,10,13,14, Anders Jacobsen Skanderup1, Joe Poh Sheng Yeong3,11, Eng-Huat Tan4,9, Caretha L Creasy15, Daniel Shao Weng Tan16,17,18, Axel M Hillmer19,20, Weiwei Zhai21,22,23,24.   

Abstract

Lung cancer is the world's leading cause of cancer death and shows strong ancestry disparities. By sequencing and assembling a large genomic and transcriptomic dataset of lung adenocarcinoma (LUAD) in individuals of East Asian ancestry (EAS; n = 305), we found that East Asian LUADs had more stable genomes characterized by fewer mutations and fewer copy number alterations than LUADs from individuals of European ancestry. This difference is much stronger in smokers as compared to nonsmokers. Transcriptomic clustering identified a new EAS-specific LUAD subgroup with a less complex genomic profile and upregulated immune-related genes, allowing the possibility of immunotherapy-based approaches. Integrative analysis across clinical and molecular features showed the importance of molecular phenotypes in patient prognostic stratification. EAS LUADs had better prediction accuracy than those of European ancestry, potentially due to their less complex genomic architecture. This study elucidated a comprehensive genomic landscape of EAS LUADs and highlighted important ancestry differences between the two cohorts.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32015526     DOI: 10.1038/s41588-019-0569-6

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  86 in total

1.  Clinical Implications of Inter- and Intratumor Heterogeneity of Immune Cell Markers in Lung Cancer.

Authors:  Wei Zhao; Bin Zhu; Amy Hutchinson; Angela Cecilia Pesatori; Dario Consonni; Neil E Caporaso; Tongwu Zhang; Difei Wang; Jianxin Shi; Maria Teresa Landi
Journal:  J Natl Cancer Inst       Date:  2022-02-07       Impact factor: 13.506

2.  Genomic and evolutionary classification of lung cancer in never smokers.

Authors:  Tongwu Zhang; Philippe Joubert; Naser Ansari-Pour; Wei Zhao; Phuc H Hoang; Rachel Lokanga; Aaron L Moye; Jennifer Rosenbaum; Abel Gonzalez-Perez; Francisco Martínez-Jiménez; Andrea Castro; Lucia Anna Muscarella; Paul Hofman; Dario Consonni; Angela C Pesatori; Michael Kebede; Mengying Li; Bonnie E Gould Rothberg; Iliana Peneva; Matthew B Schabath; Maria Luana Poeta; Manuela Costantini; Daniela Hirsch; Kerstin Heselmeyer-Haddad; Amy Hutchinson; Mary Olanich; Scott M Lawrence; Petra Lenz; Maire Duggan; Praphulla M S Bhawsar; Jian Sang; Jung Kim; Laura Mendoza; Natalie Saini; Leszek J Klimczak; S M Ashiqul Islam; Burcak Otlu; Azhar Khandekar; Nathan Cole; Douglas R Stewart; Jiyeon Choi; Kevin M Brown; Neil E Caporaso; Samuel H Wilson; Yves Pommier; Qing Lan; Nathaniel Rothman; Jonas S Almeida; Hannah Carter; Thomas Ried; Carla F Kim; Nuria Lopez-Bigas; Montserrat Garcia-Closas; Jianxin Shi; Yohan Bossé; Bin Zhu; Dmitry A Gordenin; Ludmil B Alexandrov; Stephen J Chanock; David C Wedge; Maria Teresa Landi
Journal:  Nat Genet       Date:  2021-09-06       Impact factor: 38.330

3.  Towards the understanding of the genetics of somatic mutations.

Authors:  Xiwei Sun; Jian Yang
Journal:  Br J Cancer       Date:  2021-04-07       Impact factor: 7.640

4.  Utilizing Publicly Available Cancer Clinicogenomic Data on CBioPortal to Compare Epidermal Growth Factor Receptor Mutant and Wildtype Non-Small Cell Lung Cancer.

Authors:  Chirag Dhar
Journal:  Cureus       Date:  2021-04-25

5.  Genomic landscape of ground glass opacities (GGOs) in East Asians.

Authors:  Peng Cao; Shan Hu; Kangle Kong; Peng Han; Jiaqi Yue; Yu Deng; Bo Zhao; Fan Li
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

6.  Identification of an Individualized Metabolism Prognostic Signature and Related Therapy Regimens in Early Stage Lung Adenocarcinoma.

Authors:  Junjie Hu; Huansha Yu; Liangdong Sun; Yilv Yan; Lele Zhang; Gening Jiang; Peng Zhang
Journal:  Front Oncol       Date:  2021-04-28       Impact factor: 6.244

7.  Presentation of EGFR mutations in 162 family probands with multiple primary lung cancer.

Authors:  Chunxiang Li; Yalong Wang; Kai Su; Yu Liu; Liyu Wang; Bo Zheng; Na Yan; Dawei Yuan; Yanxiang Zhang; Liyan Xue; Shugeng Gao; Jie He
Journal:  Transl Lung Cancer Res       Date:  2021-04

8.  Whole-Exome Profiling of NSCLC Among African Americans.

Authors:  Rony F Arauz; Jung S Byun; Mayank Tandon; Sanju Sinha; Skyler Kuhn; Sheryse Taylor; Adriana Zingone; Khadijah A Mitchell; Sharon R Pine; Kevin Gardner; Eliseo J Perez-Stable; Anna M Napoles; Bríd M Ryan
Journal:  J Thorac Oncol       Date:  2020-09-12       Impact factor: 15.609

Review 9.  Epidemiology and genomics of prostate cancer in Asian men.

Authors:  Yao Zhu; Miao Mo; Yu Wei; Junlong Wu; Jian Pan; Stephen J Freedland; Ying Zheng; Dingwei Ye
Journal:  Nat Rev Urol       Date:  2021-03-10       Impact factor: 14.432

10.  Somatic mutation subtypes of lung adenocarcinoma in East Asian reveal divergent biological characteristics and therapeutic vulnerabilities.

Authors:  Wai-Kok Choong; Ting-Yi Sung
Journal:  iScience       Date:  2021-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.